Sfoglia per Autore
MiRNAs and resistance to EGFRâ€"TKIs in EGFR-mutant non-small cell lung cancer: Beyond 'traditional mechanisms' of resistance
2015 Ricciuti, Biagio; Mecca, Carmen; Cenci, Matteo; Leonardi, GIULIA COSTANZA; Perrone, Lorenzo; Mencaroni, Clelia; Crino', Lucio; Grignani, Francesco; Baglivo, Sara; Chiari, Rita; Sidoni, Angelo; Paglialunga, Luca; Curra', MARIA FRANCESCA; Murano, Emanuele; Minotti, Vincenzo; Metro, Giulio
Prognostic role of expression levels of FABP3 and AKR1B10 genes in adenocarcinoma stage I patients.
2015 Ludovini, V; Siggillino, A; Bianconi, Fortunato; Pistola, L; Chiari, R; Metro, Giulio; Tofanetti, Fr; Vannucci, Jacopo; Treggiari, S; Bellezza, Guido; Sidoni, Angelo; Puma, Francesco; Crino, L.
Targeting EGFR and ALK in NSCLC: current evidence and future perspective
2016 Bennati, Chiara; Paglialunga, Luca; Ricciuti, Biagio; Metro, Giulio; Marcomigni, Luca; Gili, Alessio; Crino', Lucio
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series
2016 Metro, Giulio; Lunardi, Gianluigi; Bennati, Chiara; Chiarini, Pietro; Sperduti, Isabella; Ricciuti, Biagio; Marcomigni, Luca; Costa, Cinzia; Crino', Lucio; Floridi, Piero; Gori, Stefania; Chiari, Rita
How might treatment of ALK-positive non-small cell lung cancer change in the near future?
2016 Metro, Giulio; Bellezza, Guido; Puma, Francesco; Chiari, Rita
Targeting the KRAS variant for treatment of non-small cell lung cancer: Potential therapeutic applications
2016 Ricciuti, Biagio; Leonardi, GIULIA COSTANZA; Metro, Giulio; Grignani, Francesco; Paglialunga, Luca; Bellezza, Guido; Baglivo, Sara; Mencaroni, Clelia; Baldi, Alice; Zicari, Daniela; Crino', Lucio
Malignant giant solitary fibrous tumor of the pleura metastatic to the thyroid gland
2016 Ricciuti, Biagio; Metro, Giulio; Leonardi, GIULIA COSTANZA; Sordo, Rachele Del; Colella, Renato; Puma, Francesco; Ceccarelli, Silvia; Potenza, Rossella; Rebonato, Alberto; Maiettini, Daniele; Crino', Lucio; Chiari, Rita
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice
2016 Metro, Giulio; Ricciuti, Biagio; Chiari, Rita; Baretti, Marina; Falcinelli, Lorenzo; Giannarelli, Diana; Sidoni, Angelo; Mountzios, Giannis; Crino', Lucio; Bellezza, Guido; Rebonato, Alberto; Ferolla, Piero; Toschi, Luca
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis
2016 Ludovini, Vienna; Bianconi, Fortunato; Siggillino, Annamaria; Piobbico, Danilo; Vannucci, Jacopo; Metro, Giulio; Chiari, Rita; Bellezza, Guido; Puma, Francesco; Della Fazia, Maria Agnese; Servillo, Giuseppe; Crino', Lucio
Sacrum colon-rectal cancer metastasis: Microwave ablation for palliative pain treatment
2016 Maiettini, Daniele; DE ANGELIS, Verena; Graziosi, Luigina; Rebonato, Stefania; Falcinelli, Lorenzo; Metro, Giulio; Rebonato, Alberto
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma
2017 Bellezza, Guido; Vannucci, Jacopo; Bianconi, Fortunato; Metro, Giulio; Del Sordo, Rachele; Andolfi, Marco; Ferri, Ivana; Siccu, Paola; Ludovini, Vienna; Puma, Francesco; Sidoni, Angelo; Cagini, Lucio
Inflammatory markers as prognostic factors of survival in patients affected by hepatocellular carcinoma undergoing transarterial chemoembolization
2017 Rebonato, A.; Graziosi, L.; Maiettini, D.; Marino, E.; De Angelis, V.; Brunese, L.; Mosca, S.; Metro, G.; Rossi, M.; Orgera, G.; Scialpi, M.; Donini, A.
Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence
2017 Ricciuti, Biagio; Brambilla, Marta; Metro, Giulio; Baglivo, Sara; Matocci, Roberta; Pirro, Matteo; Chiari, Rita
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer
2017 Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Ricciuti, Biagio; Siggillino, Annamaria; Rebonato, Alberto; Messina, Salvatore; Crinò, Lucio; Chiari, Rita
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy
2017 Ricciuti, B; Baglivo, S; Paglialunga, L; De Giglio, A; Bellezza, G; Chiari, R; Crinò, L; Metro, G.
Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient.
2018 Metro, G; Baglivo, S; Siggillino, A; Ludovini, V; Chiari, R; Rebonato, A; Bellezza, G
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?
2018 De Giglio, Andrea; Porreca, Roberta; Brambilla, Marta; Metro, Giulio; Prosperi, Enrico; Bellezza, Guido; Pirro, Matteo; Chiari, Rita; Ricciuti, Biagio
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications.
2018 Mandarano, M; Bellezza, G; Belladonna, Ml; Van den Eynde, Bj; Chiari, R; Vannucci, J; Mondanelli, G; Ludovini, V; Ferri, I; Bianconi, F; Del Sordo, R; Cagini, L; Albini, E; Metro, G; Puma, F; Sidoni, A
Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients.
2018 Metro, G; Giannarelli, D; Sidoni, A; Chiari, R; Bellezza, G
Osimertinib
2018 Malapelle, Umberto; Ricciuti, Biagio; Baglivo, Sara; Pepe, Francesco; Pisapia, Pasquale; Anastasi, Paola; Tazza, Marco; Sidoni, Angelo; Liberati, Anna M; Bellezza, Guido; Chiari, Rita; Metro, Giulio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
MiRNAs and resistance to EGFRâ€"TKIs in EGFR-mutant non-small cell lung cancer: Beyond 'traditional mechanisms' of resistance | 2015 | Ricciuti, Biagio; Mecca, Carmen; Cenci, Matteo; Leonardi, GIULIA COSTANZA; Perrone, Lorenzo; Mencaroni, Clelia; Crino', Lucio; Grignani, Francesco; Baglivo, Sara; Chiari, Rita; Sidoni, Angelo; Paglialunga, Luca; Curra', MARIA FRANCESCA; Murano, Emanuele; Minotti, Vincenzo; Metro, Giulio | |
Prognostic role of expression levels of FABP3 and AKR1B10 genes in adenocarcinoma stage I patients. | 2015 | Ludovini, V; Siggillino, A; Bianconi, Fortunato; Pistola, L; Chiari, R; Metro, Giulio; Tofanetti, Fr; Vannucci, Jacopo; Treggiari, S; Bellezza, Guido; Sidoni, Angelo; Puma, Francesco; Crino, L. | |
Targeting EGFR and ALK in NSCLC: current evidence and future perspective | 2016 | Bennati, Chiara; Paglialunga, Luca; Ricciuti, Biagio; Metro, Giulio; Marcomigni, Luca; Gili, Alessio; Crino', Lucio | |
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series | 2016 | Metro, Giulio; Lunardi, Gianluigi; Bennati, Chiara; Chiarini, Pietro; Sperduti, Isabella; Ricciuti, Biagio; Marcomigni, Luca; Costa, Cinzia; Crino', Lucio; Floridi, Piero; Gori, Stefania; Chiari, Rita | |
How might treatment of ALK-positive non-small cell lung cancer change in the near future? | 2016 | Metro, Giulio; Bellezza, Guido; Puma, Francesco; Chiari, Rita | |
Targeting the KRAS variant for treatment of non-small cell lung cancer: Potential therapeutic applications | 2016 | Ricciuti, Biagio; Leonardi, GIULIA COSTANZA; Metro, Giulio; Grignani, Francesco; Paglialunga, Luca; Bellezza, Guido; Baglivo, Sara; Mencaroni, Clelia; Baldi, Alice; Zicari, Daniela; Crino', Lucio | |
Malignant giant solitary fibrous tumor of the pleura metastatic to the thyroid gland | 2016 | Ricciuti, Biagio; Metro, Giulio; Leonardi, GIULIA COSTANZA; Sordo, Rachele Del; Colella, Renato; Puma, Francesco; Ceccarelli, Silvia; Potenza, Rossella; Rebonato, Alberto; Maiettini, Daniele; Crino', Lucio; Chiari, Rita | |
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice | 2016 | Metro, Giulio; Ricciuti, Biagio; Chiari, Rita; Baretti, Marina; Falcinelli, Lorenzo; Giannarelli, Diana; Sidoni, Angelo; Mountzios, Giannis; Crino', Lucio; Bellezza, Guido; Rebonato, Alberto; Ferolla, Piero; Toschi, Luca | |
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis | 2016 | Ludovini, Vienna; Bianconi, Fortunato; Siggillino, Annamaria; Piobbico, Danilo; Vannucci, Jacopo; Metro, Giulio; Chiari, Rita; Bellezza, Guido; Puma, Francesco; Della Fazia, Maria Agnese; Servillo, Giuseppe; Crino', Lucio | |
Sacrum colon-rectal cancer metastasis: Microwave ablation for palliative pain treatment | 2016 | Maiettini, Daniele; DE ANGELIS, Verena; Graziosi, Luigina; Rebonato, Stefania; Falcinelli, Lorenzo; Metro, Giulio; Rebonato, Alberto | |
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma | 2017 | Bellezza, Guido; Vannucci, Jacopo; Bianconi, Fortunato; Metro, Giulio; Del Sordo, Rachele; Andolfi, Marco; Ferri, Ivana; Siccu, Paola; Ludovini, Vienna; Puma, Francesco; Sidoni, Angelo; Cagini, Lucio | |
Inflammatory markers as prognostic factors of survival in patients affected by hepatocellular carcinoma undergoing transarterial chemoembolization | 2017 | Rebonato, A.; Graziosi, L.; Maiettini, D.; Marino, E.; De Angelis, V.; Brunese, L.; Mosca, S.; Metro, G.; Rossi, M.; Orgera, G.; Scialpi, M.; Donini, A. | |
Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence | 2017 | Ricciuti, Biagio; Brambilla, Marta; Metro, Giulio; Baglivo, Sara; Matocci, Roberta; Pirro, Matteo; Chiari, Rita | |
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer | 2017 | Baglivo, Sara; Ludovini, Vienna; Sidoni, Angelo; Metro, Giulio; Ricciuti, Biagio; Siggillino, Annamaria; Rebonato, Alberto; Messina, Salvatore; Crinò, Lucio; Chiari, Rita | |
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy | 2017 | Ricciuti, B; Baglivo, S; Paglialunga, L; De Giglio, A; Bellezza, G; Chiari, R; Crinò, L; Metro, G. | |
Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient. | 2018 | Metro, G; Baglivo, S; Siggillino, A; Ludovini, V; Chiari, R; Rebonato, A; Bellezza, G | |
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter? | 2018 | De Giglio, Andrea; Porreca, Roberta; Brambilla, Marta; Metro, Giulio; Prosperi, Enrico; Bellezza, Guido; Pirro, Matteo; Chiari, Rita; Ricciuti, Biagio | |
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. | 2018 | Mandarano, M; Bellezza, G; Belladonna, Ml; Van den Eynde, Bj; Chiari, R; Vannucci, J; Mondanelli, G; Ludovini, V; Ferri, I; Bianconi, F; Del Sordo, R; Cagini, L; Albini, E; Metro, G; Puma, F; Sidoni, A | |
Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients. | 2018 | Metro, G; Giannarelli, D; Sidoni, A; Chiari, R; Bellezza, G | |
Osimertinib | 2018 | Malapelle, Umberto; Ricciuti, Biagio; Baglivo, Sara; Pepe, Francesco; Pisapia, Pasquale; Anastasi, Paola; Tazza, Marco; Sidoni, Angelo; Liberati, Anna M; Bellezza, Guido; Chiari, Rita; Metro, Giulio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile